文献速递肺血管病与心包/心肌炎

SPARC:肺动脉高压血管细胞功能的新型调节因子

SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
PubMed 文献 · Circulation · 2022-02-17

该研究通过微阵列分析、IPAH患者肺组织、慢性缺氧小鼠模型及原代人肺动脉平滑肌细胞(PASMC)和肺微血管内皮细胞(PMVEC)实验,识别SPARC在肺动脉高压血管重塑中的作用。SPARC在缺氧诱导PH小鼠和IPAH肺组织中上调,由TGF-β1或HIF2A信号诱导表达;PMVEC分泌的SPARC以旁分泌方式促进PASMC增殖。成年小鼠AAV介导的Sparc敲低改善PH小鼠的血流动力学和心脏功能。

要点

  • SPARC在IPAH患者和慢性缺氧PH小鼠肺组织中上调,血浆SPARC水平未升高。
  • PMVEC分泌的SPARC作为旁分泌因子触发PASMC增殖,SPARC沉默增强凋亡并减少增殖。
  • 成年小鼠AAV介导Sparc敲低显著改善PH小鼠血流动力学和心脏功能。

核心结论

  • SPARC参与人IPAH和慢性缺氧诱导小鼠PH的发病,可能通过影响血管细胞功能发挥作用。

研究设计与样本

  • 研究使用IPAH患者肺组织、慢性缺氧小鼠肺组织、原代人PASMC和PMVEC,以及AAV介导的成年小鼠Sparc敲低模型。
  • C57BL/6J小鼠暴露于常氧、慢性缺氧或慢性缺氧后不同时间点再暴露常氧,激光显微切割后进行微阵列分析。

主要发现

  • 微阵列分析显示Sparc在所有研究的再氧合时间点均下调。
  • SPARC在缺氧诱导PH小鼠和IPAH肺组织中上调,但PH患者血浆SPARC水平未升高。
  • TGF-β1或HIF2A信号通路诱导人PASMC中SPARC表达。
  • SPARC沉默增强凋亡并减少增殖;SPARC水平升高诱导PASMC而非PMVEC增殖。
  • PMVEC分泌的SPARC作为旁分泌因子触发PASMC增殖;成年小鼠AAV介导Sparc敲低显著改善PH小鼠血流动力学和心脏功能。

临床怎么用

  • SPARC可能作为肺动脉高压血管重塑的潜在治疗靶点,但需进一步临床验证。
  • 成年期Sparc敲低改善PH小鼠血流动力学和心脏功能,提示靶向SPARC可能获益。

局限性

  • 先天性Sparc敲除小鼠未受保护,可能因代偿性促增殖信号。
  • SPARC血浆水平未升高,提示其作用可能局限于肺血管局部。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary hypertension (PH) is a life-threatening disease, characterized by excessive pulmonary vascular remodeling, leading to elevated pulmonary arterial pressure and right heart hypertrophy. PH can be caused by chronic hypoxia, leading to hyper-proliferation of pulmonary arterial smooth muscle cells (PASMCs) and apoptosis-resistant pulmonary microvascular endothelial cells (PMVECs). On reexposure to normoxia, chronic hypoxia-induced PH in mice is reversible. In this study, the authors aim to identify novel candidate genes involved in pulmonary vascular remodeling specifically in the pulmonary vasculature. METHODS: After microarray analysis, the authors assessed the role of SPARC (secreted protein acidic and rich in cysteine) in PH using lung tissue from idiopathic pulmonary arterial hypertension (IPAH) patients, as well as from chronically hypoxic mice. In vitro studies were conducted in primary human PASMCs and PMVECs. In vivo function of SPARC was proven in chronic hypoxia-induced PH in mice by using an adeno-associated virus-mediated Sparc knockdown approach. RESULTS: C57BL/6J mice were exposed to normoxia, chronic hypoxia, or chronic hypoxia with subsequent reexposure to normoxia for different time points. Microarray analysis of the pulmonary vascular compartment after laser microdissection identified Sparc as one of the genes downregulated at all reoxygenation time points investigated. Intriguingly, SPARC was vice versa upregulated in lungs during development of hypoxia-induced PH in mice as well as in IPAH, although SPARC plasma levels were not elevated in PH. TGF-β1 (transforming growth factor β1) or HIF2A (hypoxia-inducible factor 2A) signaling pathways induced SPARC expression in human PASMCs. In loss of function studies, SPARC silencing enhanced apoptosis and reduced proliferation. In gain of function studies, elevated SPARC levels induced PASMCs, but not PMVECs, proliferation. Coculture and conditioned medium experiments revealed that PMVECs-secreted SPARC acts as a paracrine factor triggering PASMCs proliferation. Contrary to the authors' expectations, in vivo congenital Sparc knockout mice were not protected from hypoxia-induced PH, most probably because of counter-regulatory proproliferative signaling. However, adeno-associated virus-mediated Sparc knockdown in adult mice significantly improved hemodynamic and cardiac function in PH mice. CONCLUSIONS: This study provides evidence for the involvement of SPARC in the pathogenesis of human PH and chronic hypoxia-induced PH in mice, most likely by affecting vascular cell function.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Veith C, Vartürk-Özcan I, Wujak M, et al. SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension. Circulation. 2022. PMID: 35175782. doi:10.1161/CIRCULATIONAHA.121.057001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。